Woodman Richard Charles 4
4 · Onconova Therapeutics, Inc. · Filed Jul 10, 2020
Insider Transaction Report
Form 4
Woodman Richard Charles
Chief Medical Officer
Transactions
- Award
Stock Appreciation Right
2020-07-09+396,000→ 396,000 totalExercise: $0.56Exp: 2030-07-09→ Common Stock (396,000 underlying)
Footnotes (1)
- [F1]These stock appreciation rights vest over three years, one-third on the first anniversary of the date of grant and thereafter in 24 equal monthly installments over the following two years.